The global pharmacovigilance services market is experiencing sustained expansion as pharmaceutical and biotechnology companies increasingly prioritize patient safety monitoring, regulatory compliance, and efficient post-market surveillance capabilities. Pharmacovigilance services have evolved from basic adverse event reporting activities into sophisticated safety management ecosystems involving artificial intelligence, automated case processing, signal detection platforms, regulatory intelligence, and global compliance…

Continue Reading